BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21608334)

  • 1. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
    Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases.
    Soltész P; Dér H; Kerekes G; Szodoray P; Szücs G; Dankó K; Shoenfeld Y; Szegedi G; Szekanecz Z
    Clin Rheumatol; 2009 Jun; 28(6):655-62. PubMed ID: 19224126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.
    Végh E; Kerekes G; Pusztai A; Hamar A; Szamosi S; Váncsa A; Bodoki L; Pogácsás L; Balázs F; Hodosi K; Domján A; Szántó S; Nagy Z; Szekanecz Z; Szűcs G
    Rheumatol Int; 2020 Mar; 40(3):427-436. PubMed ID: 31848735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications.
    Szucs G; Tímár O; Szekanecz Z; Dér H; Kerekes G; Szamosi S; Shoenfeld Y; Szegedi G; Soltész P
    Rheumatology (Oxford); 2007 May; 46(5):759-62. PubMed ID: 17244666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients.
    Sidiropoulos PI; Siakka P; Pagonidis K; Raptopoulou A; Kritikos H; Tsetis D; Boumpas DT
    Scand J Rheumatol; 2009; 38(1):6-10. PubMed ID: 18991190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis.
    Dávida L; Pongrácz V; Mohamed EA; Szamosi S; Szücs G; Váncsa A; Tímár O; Csiki Z; Végh E; Soltész P; Szekanecz Z; Kerekes G
    Rheumatol Int; 2020 Mar; 40(3):415-424. PubMed ID: 31858209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis.
    Kerekes G; Soltész P; Dér H; Veres K; Szabó Z; Végvári A; Szegedi G; Shoenfeld Y; Szekanecz Z
    Clin Rheumatol; 2009 Jun; 28(6):705-10. PubMed ID: 19319624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.
    Guin A; Chatterjee Adhikari M; Chakraborty S; Sinhamahapatra P; Ghosh A
    Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab.
    Gonzalez-Juanatey C; Llorca J; Sanchez-Andrade A; Garcia-Porrua C; Martin J; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2006; 24(3):309-12. PubMed ID: 16870100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
    Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
    Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study.
    Chatterjee Adhikari M; Guin A; Chakraborty S; Sinhamahapatra P; Ghosh A
    Semin Arthritis Rheum; 2012 Apr; 41(5):669-75. PubMed ID: 22035626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Treatments for Rheumatoid Arthritis on Endothelial Dysfunction Evaluated by Flow-Mediated Vasodilation in Patients with Rheumatoid Arthritis.
    Kotani K; Miyamoto M; Ando H
    Curr Vasc Pharmacol; 2017; 15(1):10-18. PubMed ID: 27739363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of subclinical vascular disease associated with ankylosing spondylitis.
    Bodnár N; Kerekes G; Seres I; Paragh G; Kappelmayer J; Némethné ZG; Szegedi G; Shoenfeld Y; Sipka S; Soltész P; Szekanecz Z; Szántó S
    J Rheumatol; 2011 Apr; 38(4):723-9. PubMed ID: 21239756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis -- a randomized trial.
    Tam LS; Shang Q; Li EK; Wang S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Chui RK; Tseung L; Yu SL; Kuan WP; Yu CM
    J Rheumatol; 2012 Dec; 39(12):2267-75. PubMed ID: 22984272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis.
    Turiel M; Tomasoni L; Sitia S; Cicala S; Gianturco L; Ricci C; Atzeni F; De Gennaro Colonna V; Longhi M; Sarzi-Puttini P
    Cardiovasc Ther; 2010 Oct; 28(5):e53-64. PubMed ID: 20337633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.
    Hürlimann D; Forster A; Noll G; Enseleit F; Chenevard R; Distler O; Béchir M; Spieker LE; Neidhart M; Michel BA; Gay RE; Lüscher TF; Gay S; Ruschitzka F
    Circulation; 2002 Oct; 106(17):2184-7. PubMed ID: 12390945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis.
    Veselinovic MV; Zivkovic VI; Toncev S; Tasic N; Bogdanovic V; Djuric DM; Jakovljevic VLj
    Vasa; 2012 Sep; 41(5):343-51. PubMed ID: 22915531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.
    Daza L; Aguirre M; Jimenez M; Herrera R; Bollain JJ
    Clin Rheumatol; 2007 Apr; 26(4):533-7. PubMed ID: 16758372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers].
    Benucci M; Turchini S; Parrochi P; Boccaccini P; Manetti R; Cammelli E; Manfredi M
    Recenti Prog Med; 2006 Mar; 97(3):134-9. PubMed ID: 16700418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.